Key Presentations at National and International Scientific Meetings

OBERMAIR, Andreas, The Anatomy of Complications Workshop: An Educational Strategy to Improve the Training and Performance of Fellows in Gynecologic Oncology. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.

OBERMAIR, Andreas, Uterine Papillary Serous Carcinoma – The Need for a Trial. ASGO, 19th Annual Meeting of the Australian Society of Gynaecological Oncologists, Shangri-La's Rasa Sentosa Resort, Sentosa Island, Singapore, 12-16 May 2004.

OBERMAIR, Andreas, Prognostic Significance of Preoperative CA125 in FIGO Stage I Epithelial Ovarian Cancer – An Australian Multicentre Study. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.

OBERMAIR, Andreas, A New Surgical Technique to Control Major Intraoperative Bleeding in Gynaecologic Cancer patients: The Overlay Autogenous Tissue (OAT) Patch. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.

OBERMAIR, Andreas, Accuracy of the Current FIGO Staging System for Advanced Vulval Cancer Patterns of Recurrence and Disease-Free Survival in Advanced Carcinoma of the Vulva. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.

OBERMAIR, Andreas, Comparison of Total Laparoscopic Hysterectomy with Total Abdominal Hysterectomy for Endometrial Cancer – Patterns of Recurrence and Survival. The Annual Meeting on Women's Cancer, 34th Annual Meeting, Society of Gynecological Oncologists, Hilton New Orleans Riverside, New Orleans, Louisiana. Friday, January 31 – Tuesday, February 4, 2003.

OBERMAIR, Andreas, Quality of the Surgical Treatment in Ovarian Cancer Patients in Austria. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.

OBERMAIR, Andreas, Total Laparoscopic Hysterectomy for the Treatment of Endometrial Cancer: Morbidity and Patterns of Recurrence. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.

OBERMAIR, Andreas, Palliative Care in Gynaecologic Oncology – is There a Need to do More. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.

OBERMAIR A, Cheuk R, Horwood K, Janda M, Bachtiary B, Nicklin JL, Perrin LC, Crandon AJ: Hemoglobin levels before and during chemoradiation for cervical carcinoma: impact on the response of treatment. Proc of the 32nd Annual Meeting of the Society of Gynecologic Oncologists (SGO) 2001, p 73 (abstract #51).

Sevelda P, Denison U, Baumann J, Samonigg H, Krippl P, Lang A, OBERMAIR A, Wagner H: Prevalence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast 2001; 10 (Suppl 1): S37 (abstract #(83).

Bodner K, Bodner-Adler B, OBERMAIR A, Petru E, Kaider A, Czerwenka K, Leodolter S, Mayerhofer K: Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Eur J Gynaecol Oncol 2001; 22 (Suppl): 88 (abstract # 222).

Bodner K, Bodner-Adler B, OBERMAIR A, Windbichler G, Petru E, Czerwenka K, Leodolter S, Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinico-pathologic study of 31 patients. Eur J Gynaecol Oncol 2001; 22 (Suppl): 71 (abstract # 173).

OBERMAIR A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, Stoiber A, Nicklin JL, Perrin LC, Crandon AJ: The impact of anaemia on the outcome of patients undergoing concurrent chemoradiation for cervical carcinoma. Eur J Gynaecol Oncol 2001; 22 (Suppl): 67 (abstract # 162).

OBERMAIR A, Schmid BC, Stimpfl M, Fasching B, Preyer O, Leodolter S, Crandon AJ, Zeillinger R: Expression of novel MUC1 splice variants in human cervical carcinoma cell lines. Eur J Gynaecol Oncol 2001; 22 (Suppl): 57 (abstract # 134).

OBERMAIR A, Tamandl D, Hagenauer S, Nicklin JL, Perrin LC, Ward BG, Crandon AJ: Low anterior en-bloc resection and restorativbe anastomosis in advanced stage ovarian cancer: feasibility and safety. Eur J Gynaecol Oncol 2001; 22 (Suppl): 46 (abstract # 106).

Preyer O, Bachtiary B, OBERMAIR A: Angiogenesis in cervical carcinoma. Eur J Gynaecol Oncol 2001; 22 (Suppl): 26 (abstract # 52).

OBERMAIR A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Prognostic impact of tumor anemia in early-stage epithelial ovarian cancer. Eur J Cancer 1999; 35 (Suppl 4): 233 (abstract # 913).

OBERMAIR A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial derived ovarian cnacer cells in peripheral blood. Eur J Cancer 1999; 35 (Suppl 4): 107 (abstract # 374).

OBERMAIR A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Neunteufel W, Frech I, Kaider A, Kainz C for the Austrian Gynecologic Oncology Study Group: Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation & curettage (D&C) vs. hysteroscopy + D&C. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 92 (Abstract # B95).

OBERMAIR A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial derived ovarian cnacer cells in peripheral blood. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 73 (Abstract # B35).

Preyer O, Nather A, Hefler L, Tempfer C, Kaider A, Leodolter S, OBERMAIR A: Serum concentrations of hemoglobin and vascular endothelial growth factor (VEGF) in patients with epithelial ovarian cancer. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 53 (Abstract # A162).

Umek W, Preyer O, Kratochwil A, Leodolter S, OBERMAIR A: Erste Erfahrungen mit 3D Ultraschall und Levovist zur Darstellung von Gefen bei suspekten Adnexbefunden. Gynkol Geburtshilfliche Rundsch 1999; 39: 99 (abstrakt #152). [German]

Preyer O, OBERMAIR A, Breitenecker G, Leodolter S, Kainz C, Dadak C: Nikotinabusus und Rezidivhufigkeit bei Patientinnen mit Condylomata acuminata. Gynkol Geburtshilfliche Rundsch 1999; 39: 88 (abstrakt #108). [German]

OBERMAIR A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer, Neunteufel W, Frech I, Kaider A, Kainz C fr die sterreichische Arbeitsgemeinschaft Gynkologische Onkologie: Bewirkt die Hysteroskopie eine Tumorzelldissemination? Peritonealzytologie bei Endometriumkarzinom-Patientinnen mit und ohne Hysteroskopie. Gynkol Geburtshilfliche Rundsch 1999; 39: 85 (abstrakt #99). [German]

Janda M, Gerstner N, Wachter S, OBERMAIR A, Schlappack O, Ptter R: Quality of life (QOL) and fatigue in patients receiving external beam radiation for prostate cancer: Comparison of questionaires EORTC-QLQ-C30 with Medical Outcomes Study Short Form Health Survey SF-36. Proc Am Soc Clin Oncol 1999; 18:581a (abstract#2244).

OBERMAIR A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Pretreatment serum hemoglobin and survival in early-stage epithelial ovarian cancer. Proc Am Soc Clin Oncol 1999; 18:381a (abstract#1473).

OBERMAIR A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial-derived ovarian cancer cells in peripheral blood. Eur J Gynecol Oncol 1999; 20:124 (abstract #277).

Preyer O, Hefler L, Tempfer C, Wasicky R, Kaider A, Leodolter S, OBERMAIR A: Vascular endothelial growth factor (VEGF) in epithelial ovarian cancer. Eur J Gynecol Oncol 1999; 20:85 (abstract #188).

OBERMAIR A, Geramou M, Gcer F, Denison U, Graf AH, Kapshammer E, Neunteufel W, Frech I, Kaider A, Kainz C: Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation & curettage vs. hysteroscopy plus dilatation & curettage. Eur J Gynecol Oncol 1999; 20:53 (abstract #106).

Hefler L, OBERMAIR A, Tempfer C, Reinthaller A, Leodolter S, Kainz C: Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Eur J Gynecol Oncol 1999; 20:36 (abstract #68).

Mayerhofer K, OBERMAIR A, Petru E, Windbichler G, Czerwenka K, Kaider A, Kainz C, Klbl H, Leodolter S: Uterus Leiomyosarkom: Klinisch-pathologische Ergebnisse einer multizentrischen, retrospektiven Studie von 71 Fllen. Arch Gynecol Obstet 1998 (Suppl 1); 261: 128 (abstract # P2.14.17). [German]

Bancher-Todesca D, OBERMAIR A, Kohlberger P, Breitenecker G, Gitsch G: P53 - ein Prognosefaktor bei sers-papillrem Endometriumkarzinom. Arch Gynecol Obstet 1998 (Suppl 1); 261: 126 (abstract # P2.14.11). [German]

OBERMAIR A, Geramou M, Denison U, Wierrani F, Rosen A, Graf A, Nather A, Petru E, Kainz C: Hysteroskopie beim Endometriumkarzinom. Arch Gynecol Obstet 1998 (Suppl 1); 261: 124 (abstract # P2.14.02). [German]

OBERMAIR A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, Leodolter S, Gitsch G: Prognostic impact of microvessel density in stage IB carcinoma of the uterine cervix. Ann Oncol 1998 (Suppl 2); 9:78 (abstract #297).

OBERMAIR A, Speiser P, Ullrich R, Czerwenka K, Kaider A, Zeillinger R, Miksche M, Kainz C: Effect of intratumoral fibroblast growth factor-basic on ovarian cancer patients' survival. Int J Gynecol Cancer 1997;7 (Suppl 2): 69 (abstract P148).

OBERMAIR A, Wanner C, Bilgi S, Bancher-Todesca D, Kainz C, Gitsch G: Vessel invasion in carcinoma of the uterine cervix: lymphatic versus blood vessel invasion. Int J Gynecol Cancer 1997;7 (Suppl 2): 32 (abstract P002).

Thoma M, OBERMAIR A, Speiser P, Kaider A, Salzer H, Dittrich C, Sevelda P: Prediction of toxicity by determining carboplatin exposure in epithelial ovarian cancer patients treated with a combination of carboplatin and cisplatin. Int J Gynecol Cancer 1997;7 (Suppl 2): 65 (abstract P132).

Janda M, OBERMAIR A, Handisurya A, Wasicky R, Kaider A, Sevelda P, Koelbl H, Ford P: Prognostic impact of tumor anemia in patients with epithelial ovarian cancer. Proc Am Soc Clin Oncol 1997; 16: 372a (abstract #1324).

Kohlberger P, Mian C, Wiener H, OBERMAIR A, Bancher D, Kainz C, Gitsch G, Breitenecker G (Spon: Kieback D.): Numerical chromosomal aberrations in borderline, benign and malignant surface epithelial-stromal tumors of the ovary: correlation with established prognostic factors, DNA-ploidy, p53 protein overexpression and Ki-67. J Soc Gynecol Invest 1997; 4: 171 (suppl) (abstract # 367).

OBERMAIR A, Handisurya A, Bancher-Todesca D, Breitenecker G, Klbl H, Sevelda P, Gitsch G: Prognostic significance of pretreatment hemoglobin in epithelial ovarian cancer: preliminary results. Europ J Gynecol Oncol 1997; 18: 270 (abstract # 152).

OBERMAIR A, Wanner C, Bancer-Todesca D, Kohlberger P, Bilgi S, Breitenecker G, Leodolter S, Gitsch G: Tumor-angiogenesis in cervical intraepithelial neoplasia (CIN) and in invasive carcinoma of the uterine cervix (clinical stage IB). Europ J Gynecol Oncol 1997; 18: 231 (abstract #44).

Gitsch G, Wanner C, Bilgi S, Bancher-Todesca D, Kaider A, OBERMAIR A: Vessel invasion in cervical cancer: lymphatic (LVI) versus blood vessel invasion (BVI). Europ J Gynecol Oncol 1997; 18: 229-230 (abstract # 40).

Bancher-Todesca D, OBERMAIR A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G: Angiogenesis in vulvar intraepithelial neoplasia (VIN) and in vulvar cancer. Europ J Gynecol Oncol 1997; 18: 224 (abstract # 24). [German]

OBERMAIR A, Bancher-Todesca D, Bilgi S, Gitsch G: Tumorangiogenese bei der zervikalen intraepithelialen Neoplasie. Arch Gynecol Obstet 1996; 258: 171 (suppl 1) (abstract # V3.GS.09). [German]

Kohlberger P, OBERMAIR A, Sliutz G, Heinzl H, Koelbl H, Gitsch G, Kainz C, Breitenecker G: Immunhistochemische Faktor VIII bestimmung beim Mammakarzinom: Vergleich computersuntersttzte Bildanalyse mit herkmmlichen Zhlmethoden. Verh Dtsch Ges Path 1996; 80: 606 (abstract). [German]

OBERMAIR A, Kohlberger P, Sliutz G, Bancher-Todesca D, Tempfer C, Kainz C, Reinthaller A, Breitenecker G, Gitsch G: Die prognostische Bedeutung der Tumor-Angiogenese beim Vulvakarzinom. Ber Pathol 1996; 123: 3 (abstract). [German

Dittrich C, OBERMAIR A, Kurz C, Vavra N, Speiser P, Breitenecker G, Salzer H, Sevelda P for the Austrian Ovarian Cancer Study Group: Prospective randomized trial of Cisplatin/Carboplatin versus conventional Cisplatin/Cyclophosphamide in epithelial ovarian cancer: first results of the impact of platinum dose intensity on patient outcome. Proc Am Soc Clin Oncol 1996; 15: 279 (abstract).

Joura EA, OBERMAIR A, Lsch A, Sam C, Bancher-Todesca D, Joura EM, Breitenecker G, Gitsch G: Histopathological Prognostic Factors in Infiltrating Ductal Carcinoma of the Breast. Anticancer Research 1995; 15: 1829-1830 (abstract).

OBERMAIR A, Bancher-Todesca D, Bodisch A, Thoma M, Joura EA, Kurz C, Wagner T, Kaider A, Sevelda P, Gitsch G: Angiogenesis Parameters, as Microvessel Density and Vessel Invasion, rather than Established Prognostic Factors influence Breast Cancer Prognosis. Anticancer Research 1995; 15: 1826 (abstract).

OBERMAIR A, Bancher-Todesca D, Bodisch A, Thoma M, Speiser P, Zeilinger R, Kaider A, Miksche M, Sevelda P, Gitsch G: Intratumoral Basic Fibroblast Growth Factor Level influences the Outcome in Patients with Epithelial Ovarian Cancer. Anticancer Research 1995; 15: 1768 (abstract).

OBERMAIR A, Bancher-Todesca D, Bodisch A, Thoma M, Kaider A, Salzer H, Dittrich C, Gitsch G, Sevelda P: Impact of area-under-the-curve of carboplatin on response rate and overall survival in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. Anticancer Research 1995; 15: 1769-1770 (abstract).

Bancher-Todesca D, OBERMAIR A, Kurz C, Hanzal E, Bodisch A, Thoma M, Kubista E, Kaider A, Sevelda P, Gitsch G: Obesity does not influence the disease-free survival in patients with primary breast cancer. Anticancer Research 1995; 15: 1831-1832 (abstract).

Joura EA, Bancher-Todesca D, Lsch A, Zeisler H, OBERMAIR A, Breitenecker G, Gitsch G: Vulvar Intraepithelial Neoplasia (VIN): Diagnosis value of non-invasive methods. Anticancer Research 1995; 15: 1817 (abstract).

Bancher-Todesca D, OBERMAIR A, Hanzal E, Bodisch A, Thoma M, Vavra N, Sevelda P, Gitsch G: Delayed diagnosis of endometrial cancer in patients with abnormal postmenopausal bleeding. Anticancer Research 1995; 15: 1817 (abstract).

Bancher-Todesca D, Zeisler H, OBERMAIR A, Joura EA, Bodisch A, Thoma M, Kainz C, Breitenecker G, Reinthaller A, Gitsch G: Sarcoma Botryoides ( Embryonal Rhabdomyosarcoma) of the uterine cervix. Case report and current managment. Anticancer Research 1995; 15: 1719-1720 (abstract).

OBERMAIR A, Kurz, C Seiser P, Czerwenka K, Kaider A, Sevelda P: Microvessel density (MVD) and blood and lymphatic vessel invasion (BLVI) in node-negative breast cancer: effect on recurrence-free survival. Anti Cancer Drugs 1995: 6 (Suppl 2): 58 (abstract # P17).

Dittrich C, Kurz C, OBERMAIR A, Speiser P, Breitenecker G, Salzer H, Sevelda P: Prospective randomized comparison of Toxicity and dose intensity (DI) of Cisplatin (P)/Cyclophosphamide (CYC) with intensified platin of P/Carboplatin in ovarian cancer. Ann Oncol 1994, 5 (Suppl 8): 99 (abstract # O 496).

Denison U, Salzer H, OBERMAIR A, Keil M, Kurz C, Vavra N, Sevelda P: Das Mammakarzinom der Frau unter 35 Jahren. Gynkol Geburtsh Rundsch 1994; 34 (Suppl 1): 141-142. [German]

Buxbaum P, OBERMAIR A, Schreiner-Frech I, Kurz C, Vavra N, Sevelda P: Verzgerte Diagnosestellung beim fortgeschrittenen Endometriumkarzinom. Gynkol Geburtsh Rundsch 1994; 34 (Suppl 1): 154-155. [German]

OBERMAIR A, Czerwenka K, Kurz C, Schemper M, Kubista E, Sevelda P: Tumorgefinvasion und Frhrezidiv beim Mammakarzinom. Acta Chirurgica Austriaca 1993; 25 (Suppl): 103. [German]

Sevelda P, Kurz C, OBERMAIR A, Vavra N, Breitenecker G, Salzer H, Dittrich C: Prospectively randomized trial of conventional high dose Cisplatin plus Cyclophosphamide versus Cisplatin plus Carboplatin as adjuvant therapy in epithelial ovarian cancer patients: First analysis of toxicity and dose intensity. Int J Gyn Cancer 1993; 3 (Suppl 1): 68.

Sevelda P, Kurz C, OBERMAIR A, Kubista E, Salzer H for the Austrian Cooperative Breast Cancer Study Group: Hormontherapie vs. Chemo-Hormontherapie bei Patientinnen mit Hormonrezeptor positivem Mammakarzinom im Stadium I und II. Deutsche Gesellschaft fr Gynkologie und Geburtshilfe 49. Kongress; 9.-12.September 1992, Berlin. (abstract). [German]

Kurz C, Sevelda P, Scholten C, Kreiner M, OBERMAIR A, Seifert M, Czerwenka K, Kubista E: Die Bedeutung der primr vollstndigen Tumorentfernung fr den weiteren Krankheitsverlauf beim Mammakarzinom. Gynkol Geburtsh Rundsch 1992; 32 (Suppl 1): 108-109. [German]

OBERMAIR A, Seifert M, Adler A, Kubista E: A Personal Computer Based Data Bank System for the Follow-Up of Breast Cancer Patients. J Cancer Res Clin Onc 1992; 118: R47 (abstract).

Seifert M, Adler A, OBERMAIR A, Denison U, Kubista E, Sevelda P: Possibilities, advantages and disadvantages of follow-up in breast cancer. Int. J. Gynecol. Obst. 1991; XIII World Congress of Gynaecology and Obstetrics (FIGO) (abstract # 2); 190.